Published in Cell on August 29, 2013
Cyclic GMP-AMP synthase is activated by double-stranded DNA-induced oligomerization. Immunity (2013) 1.98
Cyclic di-GMP acts as a cell cycle oscillator to drive chromosome replication. Nature (2015) 1.78
Tn-Seq analysis of Vibrio cholerae intestinal colonization reveals a role for T6SS-mediated antibacterial activity in the host. Cell Host Microbe (2013) 1.68
The PAMP c-di-AMP Is Essential for Listeria monocytogenes Growth in Rich but Not Minimal Media due to a Toxic Increase in (p)ppGpp. [corrected]. Cell Host Microbe (2015) 1.65
Vibrio cholerae T3SS effector VopE modulates mitochondrial dynamics and innate immune signaling by targeting Miro GTPases. Cell Host Microbe (2014) 1.47
Self and nonself: how autophagy targets mitochondria and bacteria. Cell Host Microbe (2014) 1.36
An HD-domain phosphodiesterase mediates cooperative hydrolysis of c-di-AMP to affect bacterial growth and virulence. Proc Natl Acad Sci U S A (2015) 1.24
GEMM-I riboswitches from Geobacter sense the bacterial second messenger cyclic AMP-GMP. Proc Natl Acad Sci U S A (2015) 1.02
Structure-guided reprogramming of human cGAS dinucleotide linkage specificity. Cell (2014) 0.96
Structural basis for molecular discrimination by a 3',3'-cGAMP sensing riboswitch. Cell Rep (2015) 0.89
Ancient Origin of cGAS-STING Reveals Mechanism of Universal 2',3' cGAMP Signaling. Mol Cell (2015) 0.87
RNA-Based Fluorescent Biosensors for Live Cell Imaging of Second Messenger Cyclic di-AMP. J Am Chem Soc (2015) 0.87
Molecular evolutionary and structural analysis of the cytosolic DNA sensor cGAS and STING. Nucleic Acids Res (2014) 0.85
Group B Streptococcus Degrades Cyclic-di-AMP to Modulate STING-Dependent Type I Interferon Production. Cell Host Microbe (2016) 0.83
Hybrid promiscuous (Hypr) GGDEF enzymes produce cyclic AMP-GMP (3', 3'-cGAMP). Proc Natl Acad Sci U S A (2016) 0.83
UV Light Potentiates STING (Stimulator of Interferon Genes)-dependent Innate Immune Signaling through Deregulation of ULK1 (Unc51-like Kinase 1). J Biol Chem (2015) 0.81
c-di-GMP induction of Dictyostelium cell death requires the polyketide DIF-1. Mol Biol Cell (2014) 0.80
A Conserved Pattern of Primer-Dependent Transcription Initiation in Escherichia coli and Vibrio cholerae Revealed by 5' RNA-seq. PLoS Genet (2015) 0.80
Cyclic di-GMP: second messenger extraordinaire. Nat Rev Microbiol (2017) 0.79
STING, nanoparticles, autoimmune disease and cancer: a novel paradigm for immunotherapy? Expert Rev Clin Immunol (2014) 0.76
G-quadruplexes with (4n - 1) guanines in the G-tetrad core: formation of a G-triad·water complex and implication for small-molecule binding. Nucleic Acids Res (2015) 0.76
Crystal structure of the novel di-nucleotide cyclase from Vibrio cholerae (DncV) responsible for synthesizing a hybrid cyclic GMP-AMP. Cell Res (2014) 0.76
Alternatives to antibiotics in animal agriculture: an ecoimmunological view. Pathogens (2014) 0.75
Crosstalk Between Apoptosis and Autophagy: Environmental Genotoxins, Infection, and Innate Immunity. J Cell Death (2017) 0.75
Identification of Adjuvantic Activity of Amphotericin B in a Novel, Multiplexed, Poly-TLR/NLR High-Throughput Screen. PLoS One (2016) 0.75
Autophagy in Dictyostelium: Mechanisms, regulation and disease in a simple biomedical model. Autophagy (2016) 0.75
Pattern recognition receptors and inflammation. Cell (2010) 21.05
Toll-like receptors and their crosstalk with other innate receptors in infection and immunity. Immunity (2011) 11.15
STING is an endoplasmic reticulum adaptor that facilitates innate immune signalling. Nature (2008) 10.73
Proteolytic inactivation of MAP-kinase-kinase by anthrax lethal factor. Science (1998) 10.53
Cyclic GMP-AMP synthase is a cytosolic DNA sensor that activates the type I interferon pathway. Science (2012) 10.47
Regulation of adaptive immunity by the innate immune system. Science (2010) 8.00
Cyclic GMP-AMP is an endogenous second messenger in innate immune signaling by cytosolic DNA. Science (2012) 7.08
STING is a direct innate immune sensor of cyclic di-GMP. Nature (2011) 6.44
Regulation of cellulose synthesis in Acetobacter xylinum by cyclic diguanylic acid. Nature (2008) 6.16
The helicase DDX41 senses intracellular DNA mediated by the adaptor STING in dendritic cells. Nat Immunol (2011) 5.34
c-di-AMP secreted by intracellular Listeria monocytogenes activates a host type I interferon response. Science (2010) 5.31
Sensing and reacting to microbes through the inflammasomes. Nat Immunol (2012) 5.24
Immune signaling by RIG-I-like receptors. Immunity (2011) 5.02
Cyclic di-GMP: the first 25 years of a universal bacterial second messenger. Microbiol Mol Biol Rev (2013) 4.69
Cyclic [G(2',5')pA(3',5')p] is the metazoan second messenger produced by DNA-activated cyclic GMP-AMP synthase. Cell (2013) 3.92
Pattern recognition receptors and control of adaptive immunity. Immunol Rev (2009) 3.91
The N-ethyl-N-nitrosourea-induced Goldenticket mouse mutant reveals an essential function of Sting in the in vivo interferon response to Listeria monocytogenes and cyclic dinucleotides. Infect Immun (2010) 3.89
Patterns of pathogenesis: discrimination of pathogenic and nonpathogenic microbes by the innate immune system. Cell Host Microbe (2009) 3.86
Three cdg operons control cellular turnover of cyclic di-GMP in Acetobacter xylinum: genetic organization and occurrence of conserved domains in isoenzymes. J Bacteriol (1998) 3.81
Coordinated regulation of accessory genetic elements produces cyclic di-nucleotides for V. cholerae virulence. Cell (2012) 3.70
Cyclic GMP-AMP synthase is an innate immune sensor of HIV and other retroviruses. Science (2013) 3.61
cGAS produces a 2'-5'-linked cyclic dinucleotide second messenger that activates STING. Nature (2013) 3.60
The phosphothreonine lyase activity of a bacterial type III effector family. Science (2007) 3.18
Structural biochemistry of a bacterial checkpoint protein reveals diadenylate cyclase activity regulated by DNA recombination intermediates. Mol Cell (2008) 3.15
The innate immune DNA sensor cGAS produces a noncanonical cyclic dinucleotide that activates human STING. Cell Rep (2013) 3.08
Cyclic GMP-AMP containing mixed phosphodiester linkages is an endogenous high-affinity ligand for STING. Mol Cell (2013) 2.97
The Shigella flexneri effector OspG interferes with innate immune responses by targeting ubiquitin-conjugating enzymes. Proc Natl Acad Sci U S A (2005) 2.88
Cytoplasmic DNA innate immune pathways. Immunol Rev (2011) 2.84
c-di-AMP is a new second messenger in Staphylococcus aureus with a role in controlling cell size and envelope stress. PLoS Pathog (2011) 2.55
Common themes in the design and function of bacterial effectors. Cell Host Microbe (2009) 2.50
Structural mechanism of cytosolic DNA sensing by cGAS. Nature (2013) 2.50
Mycobacterium tuberculosis activates the DNA-dependent cytosolic surveillance pathway within macrophages. Cell Host Microbe (2012) 2.39
CD36 coordinates NLRP3 inflammasome activation by facilitating intracellular nucleation of soluble ligands into particulate ligands in sterile inflammation. Nat Immunol (2013) 2.38
MPYS is required for IFN response factor 3 activation and type I IFN production in the response of cultured phagocytes to bacterial second messengers cyclic-di-AMP and cyclic-di-GMP. J Immunol (2011) 2.31
Diversity of endotoxin and its impact on pathogenesis. J Endotoxin Res (2006) 2.24
Intranasal Poly-IC treatment exacerbates tuberculosis in mice through the pulmonary recruitment of a pathogen-permissive monocyte/macrophage population. J Clin Invest (2010) 2.22
Poxvirus protein N1L targets the I-kappaB kinase complex, inhibits signaling to NF-kappaB by the tumor necrosis factor superfamily of receptors, and inhibits NF-kappaB and IRF3 signaling by toll-like receptors. J Biol Chem (2004) 2.21
Innate immune DNA sensing pathways: STING, AIMII and the regulation of interferon production and inflammatory responses. Curr Opin Immunol (2011) 2.19
STING recognition of cytoplasmic DNA instigates cellular defense. Mol Cell (2013) 2.18
Nuclear IFI16 induction of IRF-3 signaling during herpesviral infection and degradation of IFI16 by the viral ICP0 protein. Proc Natl Acad Sci U S A (2012) 2.14
Listeria monocytogenes regulates flagellar motility gene expression through MogR, a transcriptional repressor required for virulence. Proc Natl Acad Sci U S A (2004) 2.14
Bacterial c-di-GMP is an immunostimulatory molecule. J Immunol (2007) 2.13
The helicase DDX41 recognizes the bacterial secondary messengers cyclic di-GMP and cyclic di-AMP to activate a type I interferon immune response. Nat Immunol (2012) 2.11
The vaccinia virus K1L gene product inhibits host NF-kappaB activation by preventing IkappaBalpha degradation. J Virol (2004) 2.10
Use of defined TLR ligands as adjuvants within human vaccines. Immunol Rev (2011) 2.09
The structural basis for the sensing and binding of cyclic di-GMP by STING. Nat Struct Mol Biol (2012) 2.04
Asymmetrical distribution of the second messenger c-di-GMP upon bacterial cell division. Science (2010) 1.99
Structure of human cGAS reveals a conserved family of second-messenger enzymes in innate immunity. Cell Rep (2013) 1.96
c-di-AMP reports DNA integrity during sporulation in Bacillus subtilis. EMBO Rep (2011) 1.88
Structure-function analysis of STING activation by c[G(2',5')pA(3',5')p] and targeting by antiviral DMXAA. Cell (2013) 1.82
Toll-like receptors in inflammatory bowel diseases: a decade later. Inflamm Bowel Dis (2010) 1.79
Glutamine deamidation and dysfunction of ubiquitin/NEDD8 induced by a bacterial effector family. Science (2010) 1.77
Systematic identification of conserved bacterial c-di-AMP receptor proteins. Proc Natl Acad Sci U S A (2013) 1.73
Cyclic di-AMP: another second messenger enters the fray. Nat Rev Microbiol (2013) 1.69
Analysis of the role of Bacillus subtilis σ(M) in β-lactam resistance reveals an essential role for c-di-AMP in peptidoglycan homeostasis. Mol Microbiol (2012) 1.69
Salmonella AvrA Coordinates Suppression of Host Immune and Apoptotic Defenses via JNK Pathway Blockade. Cell Host Microbe (2008) 1.69
Identification of host cytosolic sensors and bacterial factors regulating the type I interferon response to Legionella pneumophila. PLoS Pathog (2009) 1.66
Inhibition of IkappaB kinase by vaccinia virus virulence factor B14. PLoS Pathog (2008) 1.63
Identification and characterization of a loss-of-function human MPYS variant. Genes Immun (2011) 1.60
A bacterial E3 ubiquitin ligase IpaH9.8 targets NEMO/IKKgamma to dampen the host NF-kappaB-mediated inflammatory response. Nat Cell Biol (2009) 1.60
Cholera stool bacteria repress chemotaxis to increase infectivity. Mol Microbiol (2006) 1.60
The Yersinia virulence effector YopM binds caspase-1 to arrest inflammasome assembly and processing. Cell Host Microbe (2012) 1.59
Differential radial capillary action of ligand assay for high-throughput detection of protein-metabolite interactions. Proc Natl Acad Sci U S A (2011) 1.58
STING-dependent recognition of cyclic di-AMP mediates type I interferon responses during Chlamydia trachomatis infection. MBio (2013) 1.50
Cyclic di-AMP homeostasis in bacillus subtilis: both lack and high level accumulation of the nucleotide are detrimental for cell growth. J Biol Chem (2012) 1.49
A Legionella type IV effector activates the NF-kappaB pathway by phosphorylating the IkappaB family of inhibitors. Proc Natl Acad Sci U S A (2009) 1.48
Structural basis for cytosolic double-stranded RNA surveillance by human oligoadenylate synthetase 1. Proc Natl Acad Sci U S A (2013) 1.46
The bacterial second messenger c-di-GMP: mechanisms of signalling. Cell Microbiol (2011) 1.44
Cleavage of p65/RelA of the NF-kappaB pathway by Chlamydia. Proc Natl Acad Sci U S A (2007) 1.43
Species-specific inhibition of RIG-I ubiquitination and IFN induction by the influenza A virus NS1 protein. PLoS Pathog (2012) 1.43
Natural selection in a bangladeshi population from the cholera-endemic ganges river delta. Sci Transl Med (2013) 1.39
Salmonella secreted factor L deubiquitinase of Salmonella typhimurium inhibits NF-kappaB, suppresses IkappaBalpha ubiquitination and modulates innate immune responses. J Immunol (2008) 1.36
NleC, a type III secretion protease, compromises NF-κB activation by targeting p65/RelA. PLoS Pathog (2010) 1.36
NF-κB and innate immunity. Curr Top Microbiol Immunol (2011) 1.34
The EAL domain protein YciR acts as a trigger enzyme in a c-di-GMP signalling cascade in E. coli biofilm control. EMBO J (2013) 1.32
Bacterial subversion of host innate immune pathways. Science (2013) 1.29
A Salmonella type III secretion effector interacts with the mammalian serine/threonine protein kinase PKN1. Cell Microbiol (2006) 1.27
Pathogenic bacteria target NEDD8-conjugated cullins to hijack host-cell signaling pathways. PLoS Pathog (2010) 1.23
Innate immune pathways triggered by Listeria monocytogenes and their role in the induction of cell-mediated immunity. Adv Immunol (2012) 1.17
Induction of type I IFNs by intracellular DNA-sensing pathways. Immunol Cell Biol (2012) 1.11
ChlaDub1 of Chlamydia trachomatis suppresses NF-kappaB activation and inhibits IkappaBalpha ubiquitination and degradation. Cell Microbiol (2008) 1.09
Yersinia pseudotuberculosis effector YopJ subverts the Nod2/RICK/TAK1 pathway and activates caspase-1 to induce intestinal barrier dysfunction. Cell Host Microbe (2012) 1.09
Bis-(3',5')-cyclic dimeric adenosine monophosphate: strong Th1/Th2/Th17 promoting mucosal adjuvant. Vaccine (2011) 1.06
Identification of regulators of the innate immune response to cytosolic DNA and retroviral infection by an integrative approach. Nat Immunol (2012) 1.02
Exploitation of eukaryotic subcellular targeting mechanisms by bacterial effectors. Nat Rev Microbiol (2013) 1.00
HSV-1 ICP27 suppresses NF-kappaB activity by stabilizing IkappaBalpha. FEBS Lett (2008) 0.97
Radiation-sensitive gene A (RadA) targets DisA, DNA integrity scanning protein A, to negatively affect cyclic Di-AMP synthesis activity in Mycobacterium smegmatis. J Biol Chem (2013) 0.96
Prion disease and the innate immune system. Viruses (2012) 0.86
Does the gut microbiome hold clues to obesity and diabetes? Curr Biol (2013) 0.77
The origin of the Haitian cholera outbreak strain. N Engl J Med (2010) 9.85
Identification of a conserved bacterial protein secretion system in Vibrio cholerae using the Dictyostelium host model system. Proc Natl Acad Sci U S A (2006) 7.99
A virulence locus of Pseudomonas aeruginosa encodes a protein secretion apparatus. Science (2006) 7.84
Comparative genomic analysis of Vibrio cholerae: genes that correlate with cholera endemic and pandemic disease. Proc Natl Acad Sci U S A (2002) 6.19
Quorum-sensing regulators control virulence gene expression in Vibrio cholerae. Proc Natl Acad Sci U S A (2002) 6.10
A genome-scale analysis for identification of genes required for growth or survival of Haemophilus influenzae. Proc Natl Acad Sci U S A (2002) 5.70
Type VI secretion system translocates a phage tail spike-like protein into target cells where it cross-links actin. Proc Natl Acad Sci U S A (2007) 5.48
Type VI secretion apparatus and phage tail-associated protein complexes share a common evolutionary origin. Proc Natl Acad Sci U S A (2009) 4.88
New insights into Acinetobacter baumannii pathogenesis revealed by high-density pyrosequencing and transposon mutagenesis. Genes Dev (2007) 4.62
Quorum sensing-dependent biofilms enhance colonization in Vibrio cholerae. Dev Cell (2003) 4.42
Translocation of a Vibrio cholerae type VI secretion effector requires bacterial endocytosis by host cells. Cell Host Microbe (2009) 3.77
Coordinated regulation of accessory genetic elements produces cyclic di-nucleotides for V. cholerae virulence. Cell (2012) 3.70
Threonine phosphorylation post-translationally regulates protein secretion in Pseudomonas aeruginosa. Nat Cell Biol (2007) 3.63
Seasonal epidemics of cholera inversely correlate with the prevalence of environmental cholera phages. Proc Natl Acad Sci U S A (2005) 3.62
Small-molecule inhibitor of Vibrio cholerae virulence and intestinal colonization. Science (2005) 3.26
ExsE, a secreted regulator of type III secretion genes in Pseudomonas aeruginosa. Proc Natl Acad Sci U S A (2005) 3.13
Determination of the transcriptome of Vibrio cholerae during intraintestinal growth and midexponential phase in vitro. Proc Natl Acad Sci U S A (2003) 2.82
Self-limiting nature of seasonal cholera epidemics: Role of host-mediated amplification of phage. Proc Natl Acad Sci U S A (2005) 2.80
Tit-for-tat: type VI secretion system counterattack during bacterial cell-cell interactions. Cell (2013) 2.73
Genomic characterization of non-O1, non-O139 Vibrio cholerae reveals genes for a type III secretion system. Proc Natl Acad Sci U S A (2005) 2.65
Genetic diversity and virulence potential of environmental Vibrio cholerae population in a cholera-endemic area. Proc Natl Acad Sci U S A (2004) 2.59
Transmissibility of cholera: in vivo-formed biofilms and their relationship to infectivity and persistence in the environment. Proc Natl Acad Sci U S A (2006) 2.54
Role of the type III secreted exoenzymes S, T, and Y in systemic spread of Pseudomonas aeruginosa PAO1 in vivo. Infect Immun (2005) 2.47
The human pathogen Pseudomonas aeruginosa utilizes conserved virulence pathways to infect the social amoeba Dictyostelium discoideum. Proc Natl Acad Sci U S A (2002) 2.43
A defined transposon mutant library and its use in identifying motility genes in Vibrio cholerae. Proc Natl Acad Sci U S A (2008) 2.27
An open letter to Elias Zerhouni. Science (2005) 2.19
RNA-Seq-based monitoring of infection-linked changes in Vibrio cholerae gene expression. Cell Host Microbe (2011) 2.05
Pathogenicity islands and phages in Vibrio cholerae evolution. Trends Microbiol (2003) 2.03
A type III secretion system in Vibrio cholerae translocates a formin/spire hybrid-like actin nucleator to promote intestinal colonization. Cell Host Microbe (2007) 2.02
The contribution of accessory toxins of Vibrio cholerae O1 El Tor to the proinflammatory response in a murine pulmonary cholera model. J Exp Med (2002) 2.00
Identification of T6SS-dependent effector and immunity proteins by Tn-seq in Vibrio cholerae. Proc Natl Acad Sci U S A (2013) 1.91
Genetic analysis of anti-amoebae and anti-bacterial activities of the type VI secretion system in Vibrio cholerae. PLoS One (2011) 1.89
Genomic analysis of the Mozambique strain of Vibrio cholerae O1 reveals the origin of El Tor strains carrying classical CTX prophage. Proc Natl Acad Sci U S A (2007) 1.84
In vivo actin cross-linking induced by Vibrio cholerae type VI secretion system is associated with intestinal inflammation. Proc Natl Acad Sci U S A (2010) 1.79
Transcriptional profiling of Vibrio cholerae recovered directly from patient specimens during early and late stages of human infection. Infect Immun (2005) 1.78
Effect of metabolic imbalance on expression of type III secretion genes in Pseudomonas aeruginosa. Infect Immun (2004) 1.78
Bacterial genomics and pathogen evolution. Cell (2006) 1.71
Modeling the role of bacteriophage in the control of cholera outbreaks. Proc Natl Acad Sci U S A (2006) 1.68
Bile acids stimulate biofilm formation in Vibrio cholerae. Mol Microbiol (2006) 1.56
A dually active anthrax vaccine that confers protection against both bacilli and toxins. Proc Natl Acad Sci U S A (2003) 1.54
Bile acids induce cholera toxin expression in Vibrio cholerae in a ToxT-independent manner. Proc Natl Acad Sci U S A (2005) 1.51
A constitutively active variant of the quorum-sensing regulator LuxO affects protease production and biofilm formation in Vibrio cholerae. Infect Immun (2003) 1.50
Metabolic regulation of type III secretion gene expression in Pseudomonas aeruginosa. Mol Microbiol (2006) 1.47
YgbQ, a cell division protein in Escherichia coli and Vibrio cholerae, localizes in codependent fashion with FtsL to the division site. Proc Natl Acad Sci U S A (2002) 1.45
Quorum sensing and a global regulator TsrA control expression of type VI secretion and virulence in Vibrio cholerae. Proc Natl Acad Sci U S A (2010) 1.44
Virstatin inhibits dimerization of the transcriptional activator ToxT. Proc Natl Acad Sci U S A (2007) 1.42
RS1 element of Vibrio cholerae can propagate horizontally as a filamentous phage exploiting the morphogenesis genes of CTXphi. Infect Immun (2002) 1.38
Satellite phage TLCφ enables toxigenic conversion by CTX phage through dif site alteration. Nature (2010) 1.36
Distribution of genes for virulence and ecological fitness among diverse Vibrio cholerae population in a cholera endemic area: tracking the evolution of pathogenic strains. DNA Cell Biol (2008) 1.33
The opportunistic pathogen Pseudomonas aeruginosa carries a secretable arachidonate 15-lipoxygenase. Proc Natl Acad Sci U S A (2004) 1.33
Meeting cholera's challenge to Haiti and the world: a joint statement on cholera prevention and care. PLoS Negl Trop Dis (2011) 1.33
Acquisition of classical CTX prophage from Vibrio cholerae O141 by El Tor strains aided by lytic phages and chitin-induced competence. Proc Natl Acad Sci U S A (2008) 1.31
Peru-15, a live attenuated oral cholera vaccine, is safe and immunogenic in Bangladeshi toddlers and infants. Vaccine (2006) 1.31
Regulation of the stringent response is the essential function of the conserved bacterial G protein CgtA in Vibrio cholerae. Proc Natl Acad Sci U S A (2007) 1.25
2,3-butanediol synthesis and the emergence of the Vibrio cholerae El Tor biotype. Infect Immun (2006) 1.22
Combining anthrax vaccine and therapy: a dominant-negative inhibitor of anthrax toxin is also a potent and safe immunogen for vaccines. Infect Immun (2005) 1.22
Effect of phage on the infectivity of Vibrio cholerae and emergence of genetic variants. Infect Immun (2008) 1.22
Mapping the regulon of Vibrio cholerae ferric uptake regulator expands its known network of gene regulation. Proc Natl Acad Sci U S A (2011) 1.21
Characterization of the RpoN regulon reveals differential regulation of T6SS and new flagellar operons in Vibrio cholerae O37 strain V52. Nucleic Acids Res (2012) 1.20
Randomized, controlled study of the safety and immunogenicity of Peru-15, a live attenuated oral vaccine candidate for cholera, in adult volunteers in Bangladesh. J Infect Dis (2005) 1.19
Type III secretion is essential for the rapidly fatal diarrheal disease caused by non-O1, non-O139 Vibrio cholerae. MBio (2011) 1.17
Phase variable O antigen biosynthetic genes control expression of the major protective antigen and bacteriophage receptor in Vibrio cholerae O1. PLoS Pathog (2012) 1.15
CTXphi-independent production of the RS1 satellite phage by Vibrio cholerae. Proc Natl Acad Sci U S A (2003) 1.15
Functional analysis of VopF activity required for colonization in Vibrio cholerae. MBio (2010) 1.14
Reactogenicity of live-attenuated Vibrio cholerae vaccines is dependent on flagellins. Proc Natl Acad Sci U S A (2010) 1.14
Quorum-regulated biofilms enhance the development of conditionally viable, environmental Vibrio cholerae. Proc Natl Acad Sci U S A (2010) 1.09
An improved technique for isolation of environmental Vibrio cholerae with epidemic potential: monitoring the emergence of a multiple-antibiotic-resistant epidemic strain in Bangladesh. J Infect Dis (2006) 1.08
Examination of diverse toxin-coregulated pilus-positive Vibrio cholerae strains fails to demonstrate evidence for Vibrio pathogenicity island phage. Infect Immun (2003) 1.08
Genomic sequence and receptor for the Vibrio cholerae phage KSF-1phi: evolutionary divergence among filamentous vibriophages mediating lateral gene transfer. J Bacteriol (2005) 1.07
Rapid genetic analysis of Helicobacter pylori gastric mucosal colonization in suckling mice. Proc Natl Acad Sci U S A (2002) 1.07
Proteomic analysis of Vibrio cholerae outer membrane vesicles. Proc Natl Acad Sci U S A (2014) 1.06
Phage-bacterial interactions in the evolution of toxigenic Vibrio cholerae. Virulence (2012) 1.06
Decreased potency of the Vibrio cholerae sheathed flagellum to trigger host innate immunity. Infect Immun (2008) 1.06
Enhanced in vivo fitness of carbapenem-resistant oprD mutants of Pseudomonas aeruginosa revealed through high-throughput sequencing. Proc Natl Acad Sci U S A (2013) 1.05
Characterization of the Vibrio cholerae vexAB and vexCD efflux systems. Arch Microbiol (2006) 1.03
Type 6 secretion system-mediated immunity to type 4 secretion system-mediated gene transfer. Science (2013) 1.03
Genetics of stress adaptation and virulence in toxigenic Vibrio cholerae. DNA Cell Biol (2004) 1.02
DNA damage and reactive nitrogen species are barriers to Vibrio cholerae colonization of the infant mouse intestine. PLoS Pathog (2011) 1.00
Non-O1 Vibrio cholerae unlinked to cholera in Haiti. Proc Natl Acad Sci U S A (2012) 0.96
Molecular cloning and characterization of two Helicobacter pylori genes coding for plasminogen-binding proteins. Proc Natl Acad Sci U S A (2004) 0.95
Coupling mutagenesis and parallel deep sequencing to probe essential residues in a genome or gene. Proc Natl Acad Sci U S A (2013) 0.91
Vibrio cholerae proteome-wide screen for immunostimulatory proteins identifies phosphatidylserine decarboxylase as a novel Toll-like receptor 4 agonist. PLoS Pathog (2009) 0.90
Comparisons of Two Proteomic Analyses of Non-Mucoid and Mucoid Pseudomonas aeruginosa Clinical Isolates from a Cystic Fibrosis Patient. Front Microbiol (2011) 0.90
Genomic science in understanding cholera outbreaks and evolution of Vibrio cholerae as a human pathogen. Curr Top Microbiol Immunol (2014) 0.87
Quorum-sensing autoinducers resuscitate dormant Vibrio cholerae in environmental water samples. Proc Natl Acad Sci U S A (2013) 0.85
Sigma E regulators control hemolytic activity and virulence in a shrimp pathogenic Vibrio harveyi. PLoS One (2012) 0.85
Molecular mechanisms of virstatin resistance by non-O1/non-O139 strains of Vibrio cholerae. Mol Microbiol (2007) 0.85
The cyclic AMP (cAMP)-cAMP receptor protein signaling system mediates resistance of Vibrio cholerae O1 strains to multiple environmental bacteriophages. Appl Environ Microbiol (2010) 0.84
MetR-regulated Vibrio cholerae metabolism is required for virulence. MBio (2012) 0.83
Gut check: testing a role for the intestinal microbiome in human obesity. Sci Transl Med (2009) 0.82
An experimental study of phage mediated bactericidal selection & emergence of the El Tor Vibrio cholerae. Indian J Med Res (2011) 0.77
Construction of cholera toxin B subunit-producing Vibrio cholerae strains using the Mariner-FRT transposon delivery system. FEMS Immunol Med Microbiol (2007) 0.77
Construction of a Vibrio cholerae prototype vaccine strain O395-N1-E1 which accumulates cell-associated cholera toxin B subunit. Vaccine (2008) 0.75
Vibrio parahaemolyticus and its specific bacteriophages as an indicator in cockles (Anadara granosa) for the risk of V. parahaemolyticus infection in Southern Thailand. Microb Ecol (2014) 0.75